F19ANALYSIS OF BDNF VAL66MET VARIANT AND EXON IV PROMOTER METHYLATION IN AUTISM SPECTRUM DISORDER TRIOS

Silvia González-NievesAndrea LópezRoberto ChaskelClaudia Lattig2026-03-222026-03-22201910.1016/j.euroneuro.2018.08.099https://doi.org/10.1016/j.euroneuro.2018.08.099https://andeanlibrary.org/handle/123456789/57573Citaciones: 1enAlleleHeroinHaplotypeAddictionMethadoneGenotypeGeneticsMedicineAutism spectrum disorderSingle-nucleotide polymorphismF19ANALYSIS OF BDNF VAL66MET VARIANT AND EXON IV PROMOTER METHYLATION IN AUTISM SPECTRUM DISORDER TRIOSarticle